The global mesoporous silica market size was valued at USD 140.6 million in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 9.7% from 2020 to 2027. Rising product penetration in different application industries, such as chemicals, wastewater treatment, and pharmaceuticals, drives the market. Thermal stability, favorable chemical properties, and biocompatibility attributes of the product are anticipated to boost its demand in the pharmaceutical industry over the forecast period.
Increasing and effective research & development activities for cancer treatment using mesoporous silica are also expected to augment the product demand. A wide range of existing and potential applications of the product in drug delivery and wastewater treatment fields and extensive use in the chemical industry as a catalyst for the synthesis of various chemicals coupled with rising expenditure on biotechnology by the government and pharmaceutical firms are anticipated to bolster the product demand.
The market in China is expected to exhibit high growth on account of the rapid development of application industries. China is one of the potential regional markets for mesoporous silica owing to rapid industrialization and favorable pharmaceutical and chemical industry prospects. China has emerged as the global production hub for various industries, such as pharmaceuticals and chemicals, over the last three decades. A large number of multinational chemical and pharmaceutical companies have shifted their manufacturing operations to China owing to the easy availability of raw materials and favorable trade policies.
Strict regulations in Europe and North America are anticipated to hinder the market growth in these regions. Regulatory authorities, such as the Environmental Protection Agency (EPA) of the U.S. and the Health and Consumer Protection Directorate, are engaged in investigating the possible negative impacts of nanoparticles on the environment and thus on human health.
The mesoporous silica is anticipated to be in the research stage and the market is characterized by a limited number of players engaged in the production and supply of the product. However, the product is expected to witness increased applications on account of the rising awareness about its associated advantages and properties.
The MCM series segment led the global market in 2019 accounting for a revenue share of over 45%. The SBA series is projected to register the fastest CAGR over the forecast period on account of its use in diverse applications, such as pharmaceutical, chemical, and others.
The market is majorly segmented based on products into SBA series, MCM series, and other products. SBA includes SBA 15 and SBA 16 materials used from the SBA series exhibiting hexagonal and lamellar structures, respectively. The properties exhibited by the SBA series products, such as thermal and mechanical stability, high surface area, and ease of functionalization, propel their demand.
MCM series materials including MCM-41 and MCM-48 are one of the most commonly used mesoporous silica materials with the pore size ranging from 2-10 nm and exhibiting cubic, hexagonal, and lamellar mesostructures. These mesoporous materials are emerging as outstanding carriers for drug delivery systems owing to their textural properties, which enhance the loading amount of active pharmaceutical ingredients inside the pore channels.
Ordered mesoporous silica is widely used in various applications including adsorption, drug delivery, separations, catalysis, and others on account of their high surface area, pore structure, desired thermal, chemical, and mechanical properties. There are several other types of mesoporous silica materials, such as Technische Universiteit Delft (TUD), Hollow Mesoporous Silica (HMS), Folded Sheet Mesoporous (FMS), and others. The aforementioned materials also offer several advantages in drug delivery applications.
The drug delivery application segment led the market in 2019 and accounted for more than 44% of the global revenue share. The segment is projected to expand further at a steady CAGR from 2020 to 2027 owing to the burgeoning demand for mesoporous silica materials in the pharmaceutical industry. Rapid advancements in the mesoporous materials are further expected to broaden its application scope, thereby driving the product demand. Other applications include catalysis, environmental protection, and others.
High surface area, biocompatibility, and ease of surface modification offered by the product make it a key material used in the targeted delivery of active pharmaceutical ingredients in several treatments including cancer. The product plays a key role in environmental protection applications. The product usage in water treatment is emerging as a cost-effective alternative, thereby driving its demand over the forecast period. Mesoporous silica is emerging as an effective additive to enhance chemical, tribological, and thermomechanical properties of polymer-based materials.
North America led the market and accounted for a 36% share of the global revenue in 2019 owing to the rapid growth of the pharmaceutical industry and increasing expenditure on wastewater treatment. Rapid industrialization, growing environmental concerns, and stringent regulations set by various governments to maintain environmental quality are anticipated to promote the implementation of wastewater treatment processes, thereby, propelling the use of mesoporous silica over the forecast period.
The rise in the research & development process of mesoporous silica to explore potential products and their applications in various end-use industries, increased utilization of nanotechnology in biomedical and other applications are projected to boost the market growth in the region over the forecast period.
The market in Europe is expected to grow at a significant rate over the forecast period, which can be attributed to rising product demand from the pharmaceutical industry. The pharmaceutical industry is one of the significant contributors to the region’s economy. However, the U.K.’s exit from the European Union is expected to have a major impact on the growth of the pharmaceutical industry restraining the market growth for mesoporous silica in the region.
Central & South America (CSA) is anticipated to witness slower growth. Even though the market has growth capabilities owing to the availability of inexpensive labor and floor space for manufacturing and research facilities, the political instability in the region is expected to restrain the growth.
Companies, such as American Elements and Merck KGaA, are dominating the market by offering a diversified product portfolio. Manufacturers provide products on the basis of standard specifications and design specifications provided by the end-users. Companies are continuously engaged in offering products using innovative and advanced methods to meet changing demands pertaining to different application industries, such as chemicals, wastewater treatment, and pharmaceuticals. Companies are trying to increase their sales through investment, expansion, and innovation. The market is characterized by the presence of a significant consumer base across the globe with the companies operating their businesses through dedicated distribution networks. Some of the prominent players in the global mesoporous silica market include:
Merck KGaA
American Elements
Nanocomposix, Inc.
Taiyo International
Mitsubishi Chemical Corporation
MKnano
W.R.Grace & Co.
AGC Chemicals Americas, Inc.
Glantreo Ltd.
ACS Material LLC
Report Attribute |
Details |
Market size value in 2020 |
USD 151.0 million |
Market volume in 2020 |
1,771.7 Kilograms |
Revenue forecast in 2027 |
USD 295.1 million |
Volume forecast in 2027 |
4,115.9 Kilograms |
Growth Rate |
CAGR of 9.7% from 2020 to 2027 (Revenue-based) |
Base year for estimation |
2019 |
Historical data |
2016 - 2018 |
Forecast period |
2020 - 2027 |
Quantitative units |
Volume in kilograms, revenue in USD million/billion, and CAGR from 2020 to 2027 |
Report coverage |
Volume forecast, revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, application, region |
Regional scope |
North America; Europe; Asia Pacific; Central & South America; Middle East & Africa |
Country scope |
The U.S.; Canada; Mexico; Germany; The U.K.; France; Italy; Spain; China; India; Japan; South Korea; Taiwan; Brazil |
Key companies profiled |
Merck KGaA; American Elements; Nanocomposix, Inc.; Taiyo International; Mitsubishi Chemical Corporation; MKnano; W.R.Grace & Co.; AGC Chemicals Americas, Inc.; Glantreo Ltd.; ACS Material LLC |
Customization scope |
Free report customization (equivalent up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2027. For the purpose of this study, Grand View Research has segmented the global mesoporous silica market report on the basis of product, application, and region:
Product Outlook (Volume, Kilograms; Revenue, USD Million, 2016 - 2027)
MCM Series
SBA Series
Others
Application Outlook (Volume, Kilograms; Revenue, USD Million, 2016 - 2027)
Catalysis
Drug Delivery
Environmental Protection
Others
Regional Outlook (Volume, Kilograms; Revenue, USD Million, 2016 - 2027)
North America
The U.S.
Canada
Mexico
Europe
Germany
The U.K.
France
Italy
Spain
Asia Pacific
China
India
Japan
South Korea
Taiwan
Central & South America
Brazil
Middle East & Africa
b. The global mesoporous silica market size was estimated at USD 140.6 million in 2019 and is expected to reach USD 151.0 million in 2020.
b. The mesoporous silica market is expected to grow at a compound annual growth rate of 9.7% in terms of revenue from 2020 to 2027 to reach USD 295.1 million by 2027.
b. SBA series product segment dominated the mesoporous silica market with a share of 42.69% in 2019, owing to its extensive use in the pharmaceutical industry on account of its favorable properties such as enhanced thermochemical stability.
b. Some of the key players operating in the mesoporous silica market include Merck KGaA, Taiyo International, Mitsubishi Chemical Corporation, W.R. Grace & Co., Nanocomposix, Inc., MKnano, American Elements, ACS Materials LLC., AGC Chemicals Americas Inc., and Glantreo Ltd.
b. The key factors that are driving the mesoporous silica market include rising demand for materials with high thermal stability and desired mechanical and chemical properties in the pharmaceutical industry, need to have a solution for wastewater treatment, and demand for active pharmaceutical ingredients in the treatment of various diseases such as cancer.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
We value your investment and offer free customization with every report to fulfil your exact research needs.